The first part contains data on the existing human biomonitoring (HBM) systems and reference values as well as information on the interlaboratory quality assurance systems and reference materials for internal daily quality control programs.
The second part includes background information on the biomarkers of exposure to substances considered priority for HBM system in Europe (cadmium, lead, mercury, cotinine), other biomarkers used on routine basis to evaluate magnitude of exposure against the reference values or to compare the levels and trends of exposure in different regions or countries (PAHs, phthalates, volatile organic compounds, pesticides, arsenic, PCDD/PCDF, PCB¿s), and biomarkers used at present for research purposes.
According to the recently published data, in spite of the downward trend in emission to the environment, the substances considered the priority (cadmium, lead, methylmercury and nicotine) can still be regarded as the possible cause of early health effects in fetuses and children. Therefore, the implementation of biomonitoring of exposure to these substances seems to be fully justified.
For all the substances discussed in the present report, validated analytical methods, external quality assurance systems and reference materials are available.